FdaApplication
ANDA 216629
Identifiers
- fda_app_no: ANDA216629
Properties
| Property | Value |
|---|---|
| applicant_name | GRAVITI PHARMACEUTICALS PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2022-10-17 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FUROSEMIDE | FUROSEMIDE | 20MG | TABLET;ORAL |
| FUROSEMIDE | FUROSEMIDE | 40MG | TABLET;ORAL |
| FUROSEMIDE | FUROSEMIDE | 80MG | TABLET;ORAL |
3 products